Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988;96(1):7-14.
doi: 10.1007/BF02431526.

Nicotine tolerance: an analysis of the time course of its development and loss in the rat

Affiliations

Nicotine tolerance: an analysis of the time course of its development and loss in the rat

A C Collins et al. Psychopharmacology (Berl). 1988.

Abstract

The time course of the development and loss of tolerance to nicotine was measured in female rats that were injected subcutaneously (SC), twice daily with 1.6 mg/kg nicotine. Tolerance to nicotine-induced decreases in locomotor activity and body temperature were observed. Tolerance to the effects of nicotine on both of these measures developed rapidly, with maximal changes occurring within 2-4 days after initiation of treatment. The binding of L-[3H]-nicotine was measured in six brain regions. Chronic nicotine treatment resulted in increases in binding in most brain regions. The increase in binding correlated significantly with the development of tolerance. Rats that had been injected chronically with nicotine did not lose their tolerance throughout a 7-day post-treatment test period. Control levels of binding were regained in all of the brain regions except cortex by 7 days after nicotine treatment was stopped. These findings indicate that changes in receptor binding may relate to the development of tolerance but the retention of tolerance is clearly not related to the number of brain nicotinic receptors, unless nicotine-induced decreases in body temperature and locomotor activity are controlled by cortical [3H]-nicotine binding sites.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Mol Pharmacol. 1987 Feb;31(2):169-74 - PubMed
    1. Pharmacol Biochem Behav. 1975 May-Jun;3(3):471-6 - PubMed
    1. Br J Pharmacol. 1983 Feb;78(2):329-37 - PubMed
    1. J Pharmacol Exp Ther. 1985 Dec;235(3):619-28 - PubMed
    1. Pharmacol Biochem Behav. 1985 Feb;22(2):283-91 - PubMed

Publication types

LinkOut - more resources